{"&cites=17159959843973271303&as_sdt=2005&sciodt=0,5&hl=en":[{"title":"Natural history of chronic hepatitis B virus infection: what we knew in 1981 and what we know in 2005","url":"https://aasldpubs.onlinelibrary.wiley.com/doi/abs/10.1002/hep.20956","authors":["HJ Yim","HJ Yim ASF Lok"],"year":2006,"numCitations":657,"pdf":"https://aasldpubs.onlinelibrary.wiley.com/doi/pdf/10.1002/hep.20956","citationUrl":"http://scholar.google.com/scholar?cites=11148568968299528169&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:6b9vtWist5oJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=11148568968299528169&hl=en&as_sdt=2005&sciodt=0,5","publication":"Wiley Online Library","p":1,"exp":1596887653273},{"title":"Screening, prevention and treatment of viral hepatitis B reactivation in patients with haematological malignancies","url":"https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1365-2141.2006.06465.x","authors":["G Lalazar","G Lalazar D Rund","G Lalazar D Rund D Shouval"],"year":2007,"numCitations":406,"pdf":"https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1365-2141.2006.06465.x","citationUrl":"http://scholar.google.com/scholar?cites=9941688410316033365&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:VU2BlO_494kJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=9941688410316033365&hl=en&as_sdt=2005&sciodt=0,5","publication":"Wiley Online Library"},{"title":"Viral hepatitis in HIV infection","url":"https://www.nejm.org/doi/full/10.1056/nejmra065142","authors":["MJ Koziel","MJ Koziel MG Peters"],"year":2007,"numCitations":387,"pdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4144044/","citationUrl":"http://scholar.google.com/scholar?cites=356347982273975861&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:NRbeE5oA8gQJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=356347982273975861&hl=en&as_sdt=2005&sciodt=0,5","publication":"Mass Medical Soc"},{"title":"Care of patients with chronic hepatitis B and HIV co-infection: recommendations from an HIV–HBV International Panel","url":"https://journals.lww.com/aidsonline/Fulltext/2005/02180/Liver_toxicity_caused_by_nevirapine.1.aspx","authors":["V Soriano","V Soriano M Puoti","V Soriano M Puoti M Bonacini","V Soriano M Puoti M Bonacini G Brook","V Soriano M Puoti M Bonacini G Brook A Cargnel…"],"year":2005,"numCitations":281,"citationUrl":"http://scholar.google.com/scholar?cites=1544581250754683130&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:-iD2yXZ0bxUJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=1544581250754683130&hl=en&as_sdt=2005&sciodt=0,5","publication":"journals.lww.com"},{"title":"Nitazoxanide, tizoxanide and other thiazolides are potent inhibitors of hepatitis B virus and hepatitis C virus replication","url":"https://www.sciencedirect.com/science/article/pii/S016635420700397X","authors":["BE Korba","BE Korba AB Montero","BE Korba AB Montero K Farrar","BE Korba AB Montero K Farrar K Gaye","BE Korba AB Montero K Farrar K Gaye S Mukerjee…"],"year":2008,"numCitations":208,"citationUrl":"http://scholar.google.com/scholar?cites=1377463496945075830&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:doZ6msC7HRMJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=1377463496945075830&hl=en&as_sdt=2005&sciodt=0,5","publication":"Elsevier"},{"title":"Use of massively parallel ultradeep pyrosequencing to characterize the genetic diversity of hepatitis B virus in drug-resistant and drug-naive patients and to detect …","url":"https://jvi.asm.org/content/83/4/1718.short","authors":["M Solmone","M Solmone D Vincenti","M Solmone D Vincenti MCF Prosperi…"],"year":2009,"numCitations":177,"pdf":"https://jvi.asm.org/content/jvi/83/4/1718.full.pdf","citationUrl":"http://scholar.google.com/scholar?cites=11477023366669901301&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:9Z03sfGTRp8J:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=11477023366669901301&hl=en&as_sdt=2005&sciodt=0,5","publication":"Am Soc Microbiol"},{"title":"Modeling the transmission dynamics and control of hepatitis B virus in China","url":"https://www.sciencedirect.com/science/article/pii/S0022519309004731","authors":["L Zou","L Zou W Zhang","L Zou W Zhang S Ruan"],"year":2010,"numCitations":147,"citationUrl":"http://scholar.google.com/scholar?cites=12486966040655827798&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:VhOoh3SdSq0J:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=12486966040655827798&hl=en&as_sdt=2005&sciodt=0,5","publication":"Elsevier"},{"title":"Selection of chronic hepatitis B therapy with high barrier to resistance","url":"https://www.sciencedirect.com/science/article/pii/S1473309911703140","authors":["R Gish","R Gish JD Jia","R Gish JD Jia S Locarnini","R Gish JD Jia S Locarnini F Zoulim"],"year":2012,"numCitations":145,"pdf":"https://www.academia.edu/download/40310701/Selection_of_chronic_hepatitis_B_therapy20151123-25162-h553u.pdf","citationUrl":"http://scholar.google.com/scholar?cites=11061816899323774543&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:T0abptx3g5kJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=11061816899323774543&hl=en&as_sdt=2005&sciodt=0,5","publication":"Elsevier"},{"title":"Temporal relationship between hepatitis B virus enhancer II/basal core promoter sequence variation and risk of hepatocellular carcinoma","url":"https://gut.bmj.com/content/57/1/91.short","authors":["YC Chou","YC Chou MW Yu","YC Chou MW Yu CF Wu","YC Chou MW Yu CF Wu SY Yang","YC Chou MW Yu CF Wu SY Yang CL Lin","YC Chou MW Yu CF Wu SY Yang CL Lin CJ Liu…"],"year":2008,"numCitations":139,"citationUrl":"http://scholar.google.com/scholar?cites=15951486992844701179&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:-73Fx-cQX90J:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=15951486992844701179&hl=en&as_sdt=2005&sciodt=0,5","publication":"gut.bmj.com"},{"title":"Entecavir for the treatment of chronic hepatitis B","url":"https://www.tandfonline.com/doi/abs/10.1586/14789072.2.6.853","authors":["T Shaw","T Shaw S Locarnini"],"year":2004,"numCitations":131,"citationUrl":"http://scholar.google.com/scholar?cites=2463742774141144622&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:Lk6e5v_4MCIJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=2463742774141144622&hl=en&as_sdt=2005&sciodt=0,5","publication":"Taylor & Francis"}]}